Letter to the Editor in Response to Khazanchi et al.
作者信息
Nayak Aditi, Islam Shabatun J, Mehta Anurag, Quyyumi Arshed A
机构信息
Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
Emory Clinical Cardiovascular Research Institute, Atlanta, GA, USA.
出版信息
J Gen Intern Med. 2021 Apr;36(4):1113-1114. doi: 10.1007/s11606-021-06594-y. Epub 2021 Jan 19.
Abstract
摘要
相似文献
1
Letter to the Editor in Response to Khazanchi et al.致编辑的信：回应卡赞奇等人
J Gen Intern Med. 2021 Apr;36(4):1113-1114. doi: 10.1007/s11606-021-06594-y. Epub 2021 Jan 19.
2
No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].关于控制新冠病毒，向美国重新引入口服脊髓灰质炎疫苗没有作用[对Chumakov等人给编辑的信的回应]
Risk Anal. 2021 Feb;41(2):389-392. doi: 10.1111/risa.13671.
3
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0
信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
4
Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al.致编辑的信：关于高某等人对无症状严重急性呼吸综合征冠状病毒2（SARS-CoV-2）携带者传染性的研究
Respir Med. 2022 Jan;191:106061. doi: 10.1016/j.rmed.2020.106061. Epub 2020 Jun 9.
5
[Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].[致编辑的信：关于托雷斯 - 科斯塔等人的“眼科中的SARS-CoV-2：临床实践的当前证据和建议”]
Acta Med Port. 2021 Jan 4;34(1):63. doi: 10.20344/amp.14855. Epub 2020 Oct 22.
6
Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.致编辑的信 回复：莱克等人，2022年对富尔福德等人，2021年《一种用于检测抗SARS-CoV-2中和抗体的即时侧流检测法》的评论
EBioMedicine. 2022 Mar;77:103899. doi: 10.1016/j.ebiom.2022.103899. Epub 2022 Mar 9.
7
Response to Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".对维奥拉等人致编辑的信的回复：“骨化二醇治疗与新冠病毒病相关结局”
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5281-e5282. doi: 10.1210/clinem/dgab566.
8
Emerging pulmonary histopathological findings in COVID-19 patients- a letter to the editor in response to Grosse et al. 2020.COVID-19患者新出现的肺部组织病理学发现——致编辑的一封信，回应格罗斯等人（2020年）
Cardiovasc Pathol. 2021 Mar-Apr;51:107302. doi: 10.1016/j.carpath.2020.107302. Epub 2020 Nov 3.
9
Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".致编辑的信的回复：COVID-19患者的肺部超声——阴影多于信息——致编辑的信，关于文章“W. LU等人，《医学超声》，2020年4月15日”
Ultraschall Med. 2020 Aug;41(4):441-442. doi: 10.1055/a-1184-4807. Epub 2020 Jun 25.
10
Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).对辛格和迪巴尔就文章《COVID-19：从实验室到临床》（辛格等人著）致编辑的信的回复信。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):865. doi: 10.1016/j.dsx.2020.06.012. Epub 2020 Jun 12.
引用本文的文献
1
County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry.县级社会脆弱性与 COVID-19 住院患者的院内死亡和主要不良心血管事件相关：美国心脏协会 COVID-19 心血管疾病登记分析。
Circ Cardiovasc Qual Outcomes. 2022 Aug;15(8):e008612. doi: 10.1161/CIRCOUTCOMES.121.008612. Epub 2022 Jul 18.
Zotero 插件